AstraZeneca gets CDSCO Panel Nod To Import, Market Andexanet alfa powder for solution for infusion Dr. Divya Colin27 Oct 2023 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
High Bleeding Risk with 5mg Apixaban among patients with Atrial Fibrillation with CKD compared to lower dose Jacinthlyn Sylvia26 Sept 2023 9:30 AM ISTA recent study published in the Circulation Journal found the potential risks and benefits associated with different doses of apixaban in patients...
Amiodarone use in AF patients increases bleeding risk in patients on apixaban or rivaroxaban Dr. Kamal Kant Kohli29 May 2023 9:45 AM ISTUSA: Using amiodarone in patients aged 65 years or older with atrial fibrillation during apixaban or rivaroxaban (anticoagulants) raises the risk for...
Apixaban safer than other options for long-term anticoagulation among the elderly with AF Aditi15 April 2023 9:30 AM ISTAccording to an Original Investigation on Cardiology published in JAMA Network Open entitled, "Comparative Effectiveness and Safety of Oral...
Can higher dose of blood thinners improve outcomes in patients hospitalized for COVID-19? Dr. Kamal Kant Kohli4 April 2023 12:30 PM ISTUSA: A higher dose of blood-thinning medication than usual in noncritically ill patients hospitalized for COVID-19 did not significantly reduce death...
DOACs better alternative than LMWH for cancer-associated thrombosis Dr. Kamal Kant Kohli28 Dec 2022 11:00 AM ISTResearchers have found in a new study that DOACs is a better alternative than LMWH for cancer-associated thrombosis. The cost-effectiveness analysis...
Are non-vitamin K oral anticoagulants feasible for patients with atrial fibrillation on hemodialysis? Medha Baranwal4 Dec 2022 8:00 PM ISTGermany: A recent study comparing apixaban and vitamin K antagonist (VKA) in atrial fibrillation (AF) patients on hemodialysis revealed no differences...
Apixaban patent Violation: HC reprimands BDR Pharma for callousness in implementing court order Farhat Nasim24 Nov 2022 12:24 PM ISTNew Delhi: Coming down heavily on BDR Pharmaceuticals International, the Delhi High Court has warned the Mumbai-based drug maker against its 'callous...
Apixaban associated with lower risk of GI bleeding compared to all DOACs Dr. Kamal Kant Kohli1 Nov 2022 2:45 AM ISTA multinational cohort study of persons with atrial fibrillation (AF) found that compared with all direct oral anticoagulants (DOACs), apixaban was...
Oral anticoagulation with apixaban after TAVR not superior to the standard of care: Study Medical Dialogues Editorial Team25 May 2022 8:00 AM ISTFrance: In a new study conducted by Jean-Philippe Collet and the team, it was shown that Apixaban was not superior to the standard of care after...
Asundexian found to have reduced bleeding risk compared to apixaban in AF patients: Study Dr. Shravani Dali28 April 2022 9:15 AM ISTAsundexian was found to have reduced bleeding risk compared to apixaban in atrial fibrillation (AF) atrial fibrillationpatients, according to a...
Investigational Anti-Clotting Drug Asundexian cuts Bleeding Risk Among AF Patients: Lancet Dr. Kamal Kant Kohli5 April 2022 9:00 AM ISTDURHAM, N.C-A new type of anti-clotting drug Asundexian, caused fewer bleeding incidents among patients with atrial fibrillation than the commonly...
